Profile
ACHV NVO VRTX REGN SGEN ARGX
Company Name Achieve Life Sciences, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $126.90M $459.47B $102.31B $75.85B $43.15B $37.66B
Employees 0.02K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Dr. Richard A. B. Stewart Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ACHV NVO VRTX REGN SGEN ARGX
Quant Rating Score 1 3 3 4 3 1
Quant Rating Strong Sell Neutral Neutral Buy Neutral Strong Sell
Trading
ACHV NVO VRTX REGN SGEN ARGX
Last Close $3.69 $85 $397.27 $701.85 $228.74 $623.82
High 52 $5.5 $146.91 $516.74 $1201.76 $228.74 $638.33
Low 52 $3.69 $85 $392.81 $701.85 $228.74 $356.01
Price vs. 52 Week High -32.91 % -42.14 % -23.12 % -41.6 % 0 % -2.27 %
Price vs. 52 Week Low 0 % 0 % 1.14 % 0 % 0 % 75.23 %
Total Return
ACHV NVO VRTX REGN SGEN ARGX
1 Month Return -13.99 % -19.09 % -11.91 % -4.9 % 0 % 2.95 %
3 Month Return -19.78 % -33.34 % -14.55 % -38.7 % 0 % 17.04 %
6 Month Return -25.75 % -40.12 % -15.24 % -33.36 % 0 % 58.14 %
9 Month Return -19.52 % -34.08 % -4.5 % -27.48 % 0 % 54.84 %
YTD Return -10.44 % -17.83 % -2.36 % -20.09 % 0 % 63.98 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACHV NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.68 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -4157.5 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
ACHV NVO VRTX REGN SGEN ARGX
Asset Growth -35.37 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth 3.39 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth - 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year - 90.03 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year - 123.63 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year -100 % 65.69 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth 33.21 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth 28.8 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share 72.11 % 106.26 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share 97.92 % 133.27 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share 99.97 % 98.1 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth 33.21 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) 34.81 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG 75.09 % 117.73 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG 97.96 % 162.84 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG 99.98 % 150.28 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth 62.03 % 51.88 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth 62.03 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -109.32 % 28.67 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share -100.53 % 74.77 % 104.06 % 137.56 % 33.72 % 93.75 %
Share Holder 5 Year Equity Growth Per Share -100.08 % 121.34 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share -100 % 49.24 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth - 26.56 % - - - -
Dividend 3 Year Growth Per Share - 63.98 % - - - -
Dividend 5 Year Growth Per Share - 79.57 % - - - -
Dividend 10 Year Growth Per Share - 94.94 % - - - -
Debt Growth 3.29 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth 34.75 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
ACHV NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM - 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM -68.75 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -108.3 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -45.7 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 174.96 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM - 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM -253.94 % 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM - 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 0.17 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM - 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM - 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -0.73 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -0.73 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 124.9 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM - 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.02 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM -253.94 % 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -5.09 38.84 -87.91 22.46 -141.85 -178.29
Price To Operating Cash Flows Ratio TTM -5.08 22.2 -121.64 17.86 -203.89 -257.55
Price Cash Flow Ratio TTM -5.08 22.2 -121.64 17.86 -203.89 -257.55
Income Statement (TTM)
ACHV NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $-0B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 0% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.03B $114.63B $4.61B $4.69B $-0.62B $-0.22B
Net Income $-0.03B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -1.5 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ACHV NVO VRTX REGN SGEN ARGX
Long Term Debt $0B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.02B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $-0B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0.02B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.02B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ACHV NVO VRTX REGN SGEN ARGX
Net Income $-0.03B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 3.39
ABCL AbCellera Biologics Inc. 2.85
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.7
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.85
ABSI Absci Corporation 2.99
ABUS Arbutus Biopharma Corporation 3.21
ABVC ABVC BioPharma, Inc. 0.524
ABVX Abivax SA American Depositary Shares 7.65
ACAD ACADIA Pharmaceuticals Inc. 16.87
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9811
ACIU AC Immune SA 2.68
ACLX Arcellx, Inc. 75.54
ACRV Acrivon Therapeutics, Inc. Common Stock 6.71
ACST Acasti Pharma Inc. 3.37
ACXP Acurx Pharmaceuticals, Inc. 0.825
ETFs With Exposure to ACHV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00464 221.92
VTI Vanguard Total Stock Market Index Fund 0 293.28
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 129.79
IWN iShares Russell 2000 Value ETF 0.00382 164.11
IWO iShares Russell 2000 Growth ETF 0.00575 290.85
VXF Vanguard Extended Market Index Fund 0 192.94
HDG ProShares Hedge Replication ETF 0.000670963 49.812
UWM ProShares Ultra Russell2000 0.00187312 42.52
VTHR Vanguard Russell 3000 Index Fund 0 263.02
IWC iShares Micro-Cap ETF 0.03324 129.75
URTY ProShares UltraPro Russell2000 0.000903473 50.52
VTWV Vanguard Russell 2000 Value Index Fund 0 145.51
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 212.69
VTWO Vanguard Russell 2000 Index Fund 0.01 90.05
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.36 30.95
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 101.62
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 101.6
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.34
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.33
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.33
JMBS Janus Henderson Mortgage-Backed Securities ETF 0.11 44.43
JCPB JPMorgan Core Plus Bond ETF 0.01 46.28
JSCP JPMorgan Short Duration Core Plus ETF 0.05 46.7
VTSAX Vanguard Total Stock Market Index Fund 0 142.69
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 146.27
VITSX Vanguard Total Stock Market Index Fund 0 142.71
DFSU Dimensional US Sustainability Core 1 ETF 0.00000331 38.1594
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000185066 99.94
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 146.28
JPIE JPMorgan Income ETF 0 45.75
SURI Simplify Propel Opportunities ETF 1.12576 16.7899
VEMPX Vanguard Extended Market Index InstlPlus 0 360.98
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 267.71
RSSL Global X Funds 0.01 87.16
Unlock